COMP vs IONS · rev $5.63B vs rev $226.6M
Compass Inc (COMP) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Compass Inc (COMP) is a real estate services company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
COMP currently screens at market cap $3.35B. IONS currently screens at market cap $12.28B.
Not investment advice. Open the COMP and IONS stock pages for the full models.
Not investment advice.